🕵️ Processa Pharmaceuticals, Inc. ($PCSA)
SEC insider & ownership activity, last 12 months · CIK 1533743 · every row links its SEC filing
Over the last 12 months insiders bought $198K with no open-market selling against it. Skibsted Russell bought $42K (Mar–Jun). HX Entertainment Ltd added 10.9% → 13.0%. One red-flag 8-K in the window: Delisting notice (3.01), Aug 7, 2025.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
9 buyers, $198K (40 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Skibsted Russell | 7 | $42K | 0 | – | Jun 30, 2026 |
| George K. Ng | 6 | $33K | 0 | – | Jul 1, 2026 |
| Guy Wendy | 7 | $33K | 0 | – | Jun 30, 2026 |
| Young David | 7 | $32K | 0 | – | Jun 30, 2026 |
| Lin Patrick | 7 | $28K | 0 | – | Jun 30, 2026 |
| Bigora Sian | 3 | $16K | 0 | – | Apr 30, 2026 |
| Baluch Khoso | 1 | $6K | 0 | – | Mar 31, 2026 |
| Pannu Geraldine | 1 | $5K | 0 | – | Mar 31, 2026 |
| James R. Neal | 1 | $2K | 0 | – | Mar 31, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| HX Entertainment Ltd | 13.0% | 13D | Feb 13, 2026 | filing ↗ | |
| Mitchell P. Kopin | 8.1% | 13G | Feb 13, 2026 | filing ↗ | |
| Daniel B. Asher | 8.1% | 13G | Feb 13, 2026 | filing ↗ | |
| Intracoastal Capital LLC | 8.1% | 13G | Feb 13, 2026 | filing ↗ | |
| CVI Investments, Inc. | 7.0% | 13G | May 15, 2026 | filing ↗ | |
| Heights Capital Management, Inc. | 7.0% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 23, 2026 | filing ↗ |
| Agreement terminated (1.02) | Jul 23, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Jul 23, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jul 23, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 23, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jul 23, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 23, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Agreement terminated (1.02) | Feb 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 12, 2026 | filing ↗ |
| Other events (8.01) | Jan 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 6, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Dec 12, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Dec 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 12, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Sep 11, 2025 | filing ↗ |
| Shareholder vote (5.07) | Sep 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 11, 2025 | filing ↗ |
| Shareholder vote (5.07) | Sep 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 11, 2025 | filing ↗ |
| Shareholder vote (5.07) | Sep 10, 2025 | filing ↗ |
| Shareholder vote (5.07) | Sep 2, 2025 | filing ↗ |
| Other events (8.01) | Aug 25, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 25, 2025 | filing ↗ |
| Delisting notice (3.01) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |
| Material agreement (1.01) | Aug 4, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 4, 2025 | filing ↗ |